We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
+15.25%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$2.49B
AUM Growth
+$561M
Cap. Flow
+$953M
Cap. Flow %
38.26%
Top 10 Hldgs %
19.27%
Holding
3,069
New
440
Increased
1,231
Reduced
593
Closed
189
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSCH icon
701
Invesco S&P SmallCap Health Care ETF
PSCH
$168M
$290K 0.01%
4,731
+2,967
+168% +$148K
WRK
702
DELISTED
WestRock Company
WRK
$290K 0.01%
5,461
-118,436
-96% -$4.89M
ECL icon
703
Ecolab
ECL
$79.9B
$288K 0.01%
2,178
+929
+74% +$194K
KEY icon
704
KeyCorp
KEY
$24.4B
$288K 0.01%
21,337
-5,089
-19% -$74.1K
IJT icon
705
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.42B
$286K 0.01%
3,666
+1,422
+63% +$145K
PWS icon
706
Pacer WealthShield ETF
PWS
$24.7M
$286K 0.01%
9,226
-1,161
-11% -$31.8K
SPTI icon
707
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
$286K 0.01%
8,890
+6,580
+285% +$218K
INCE
708
Franklin Income Equity Focus ETF
INCE
$138M
$285K 0.01%
+6,516
New +$265K
MTB icon
709
M&T Bank
MTB
$36.2B
$284K 0.01%
1,832
+5
+0.3% +$569
VSGX icon
710
Vanguard ESG International Stock ETF
VSGX
$6.74B
$283K 0.01%
5,367
+1,002
+23% +$55.5K
XLG icon
711
Invesco S&P 500 Top 50 ETF
XLG
$11B
$282K 0.01%
12,800
+10,700
+510% +$291K
PH icon
712
Parker-Hannifin
PH
$135B
$280K 0.01%
952
+69
+8% +$17.1K
ALNY icon
713
Alnylam Pharmaceuticals
ALNY
$29.3B
$276K 0.01%
+2,010
New +$268K
CARR icon
714
Carrier Global
CARR
$52.8B
$275K 0.01%
6,922
-892
-11% -$32.3K
EPI icon
715
WisdomTree India Earnings Fund ETF
EPI
$2.06B
$274K 0.01%
8,651
-4,973
-37% -$130K
MOAT icon
716
VanEck Morningstar Wide Moat ETF
MOAT
$12.3B
$273K 0.01%
13,754
+11,088
+416% +$653K
ONEQ icon
717
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.9B
$273K 0.01%
8,140
+4,360
+115% +$203K
ADM icon
718
Archer Daniels Midland
ADM
$36.9B
$272K 0.01%
4,946
+688
+16% +$34K
DG icon
719
Dollar General
DG
$27.9B
$272K 0.01%
3,450
+2,282
+195% +$487K
NTR icon
720
Nutrien
NTR
$30.7B
$271K 0.01%
4,882
+1,335
+38% +$59K
NARI
721
DELISTED
Inari Medical, Inc. Common Stock
NARI
$271K 0.01%
2,621
+121
+5% +$8.55K
PENN icon
722
PENN Entertainment
PENN
$2.71B
$270K 0.01%
4,051
+1,525
+60% +$109K
SMDV icon
723
ProShares Russell 2000 Dividend Growers ETF
SMDV
$707M
$269K 0.01%
10,670
+7,216
+209% +$388K
WTRG icon
724
Essential Utilities
WTRG
$11.4B
$269K 0.01%
6,101
+134
+2% +$5.95K
ATCO
725
DELISTED
Atlas Corp.
ATCO
$269K 0.01%
18,869

Similar funds

Geneos Wealth Management's Q4 2020 Portfolio in Review

As of Q4 2020, Geneos Wealth Management held 3,069 positions worth $2.49B, up 29% from $1.93B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneos Wealth Management deployed $953M of net new capital in Q4 2020, opening 440 new positions and adding to 1,231 existing holdings. Its largest new stake was ProShares Ultra Financials: 1,013,942 shares worth $53.6M.

By sector, the portfolio is most concentrated in Technology at 7.5% of assets, down from 7.9% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $19.8M trimmed.

  • Geneos Wealth Management's largest Q4 2020 buy was ProShares Ultra Financials: 1,013,942 shares worth $53.6M.
  • Geneos Wealth Management added most to State Street SPDR Portfolio S&P 500 ETF in Q4 2020, an estimated $45M increase.
  • Geneos Wealth Management's biggest Q4 2020 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $19.8M.
  • Geneos Wealth Management fully exited CrossFirst Bankshares, Inc. Common Stock in Q4 2020, selling an estimated $1.18M.
  • Geneos Wealth Management's ten largest holdings make up 19% of its $2.49B portfolio in Q4 2020.
  • Geneos Wealth Management opened 440 new positions and closed 189 in Q4 2020.
  • Geneos Wealth Management's portfolio value rose 29% quarter-over-quarter to $2.49B.

Based on Geneos Wealth Management's 13F filing for Q4 2020, filed 19 May 2021.